A new publication involving GHK was released on August 10, 2026. The paper is titled "EGCG-Biotin-Pal-GHK composition modulates TGF-β and BMP pathways in scalp microenvironment for treating stress-induced alopecia." It appears in the European Journal of Pharmacology.
The publication is indexed under PubMed ID 42575238. According to the title, the research examines a composition combining EGCG, biotin, and Pal-GHK, and its relationship to TGF-beta and BMP signaling pathways within the scalp microenvironment, in the context of stress-induced alopecia.
This brief reports only that the publication exists and states its title, journal, and date as provided. No findings, results, or conclusions from the study are described here, as none were included in the available event data. Readers interested in the full scope of the research should consult the original article directly through the linked source.
GHK remains classified as an approved compound. For additional background on GHK, readers can refer to the compound overview.</body_markdown>
<parameter name="sources">["https://pubmed.ncbi.nlm.nih.gov/42575238/"]